P53 transcriptionally activates miR-34, thereby inhibiting SNAI1 expression and consequently suppressing SNAI1-driven epithelial–mesenchymal transition (EMT) and tumor cell invasion [37]. The gene discussed is TP53; the disease is neoplasm.